The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlpha Growth Regulatory News (ALGW)

Share Price Information for Alpha Growth (ALGW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.20
Bid: 1.10
Ask: 1.30
Change: 0.00 (0.00%)
Spread: 0.20 (18.182%)
Open: 1.20
High: 1.20
Low: 1.20
Prev. Close: 1.20
ALGW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

29 Sep 2023 11:00

RNS Number : 0885O
Alpha Growth PLC
29 September 2023
 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

Alpha Growth plc

 

Unaudited interim report for period ended

 

30 June 2023

 

 

Chairman's Statement

PERIOD ENDED 30 JUNE 2023

 

I am pleased to announce our unaudited interim financial results for the period to 30 June 2023.

The key highlights during the period were as follows:

· 53% increase in revenues compared to equivalent period;

· Net assets more than doubled compared to net assets as at June 2022;

· Continuing progress on integrating the insurance businesses with opportunities identified to enhance profitability;

· Bought out the minority interests in Northstar Group (Bermuda) Limited whilst further aligning the interests of Dan Gray with the Group through a share-to-share exchange; and

· Released share-based payment reserves following the expiry of over 25 million options attributable to former directors and employees.

The relatively small drop in losses reflects the transition and integration costs associated with Alpha International Life Assurance Company that are now largely resolved. 

We expect our cash flow to improve, and we continue to believe that we will not require a placing of shares, unless it is for strategic acquisition and growth purposes. 

We continue to advance our buy and build strategy to ensure continued and substantive ongoing growth of the business. We continue to be presented with and review potential acquisitions that are both complementary and supplementary to its existing businesses which will further enhance free cash flow and move us close to executing the 2B plan. To this end, the appointment of Jason Sutherland as a full-time executive has greatly enhanced our ability to identify and undertake due diligence on potential targets.

Our strategy continues to insulate us from a lot of the volatility in capital markets although we appreciate that our share price performance continues to disappoint. The Directors firmly believe that the value creation strategy will feed through to the share price as the Company looks to continue to deliver on their stated goals.

I would like to take this opportunity to thank the shareholders for their continued support as we build Alpha Growth into a significant organisation within its sector.

Gobind Sahney

Chairman

29 September 2023

 

 

 

 

For more information, please visit www.algwplc.com or contact the following:

Alpha Growth plc

+44 (0) 20 3959 8600

Gobind Sahney, Executive Chairman

info@algwplc.com

 

Allenby Capital Limited

+44 (0) 20 3328 5656

Amrit Nahal (Sales and Corporate Broking)

Nick Athanas / Piers Shimwell (Corporate Finance)

 

UK Investor Relations - Mark Treharne

ir@algwplc.com

 

RESULTS FOR THE PERIOD

INTERIM PERIOD ENDED 30 June 2023

 

The results of the Group have been addressed above in the Chairman's statement.

Responsibility Statement

We confirm that to the best of our knowledge:

(a) the condensed set of financial statements has been prepared in accordance with IAS 34 'Interim Financial Reporting';

(b) the interim management report includes a fair review of the information required by DTR 4.2.7R (indication of important events during the first six months and description of principal risks and uncertainties for the remaining six months of the year; and

(c) the interim management report includes a fair review of the information required by DTR 4.2.8R (disclosure of related parties' transactions and changes therein).

 

CAUTIONARY STATEMENT

This Interim Management Report (IMR) has been prepared solely to provide additional information to shareholders to assess the Company's strategies and the potential for those strategies to succeed. The IMR should not be relied on by any other party or for any other purpose.

Going Concern

The Directors have a reasonable expectation that the Group has adequate resources to continue in operation or existence for the foreseeable future thus we continue to adopt the going concern basis in preparing these interim financial statements. As detailed in the Chairman's statement the on-going expected timing of transactions that the Company plans to be involved in and generate fees from, continue as planned and therefore should benefit the Group in the longer term.

PRINCIPAL RISKS AND UNCERTAINTIES

The principal risks and uncertainties affecting the business activities of the Group remain those detailed in the Prospectus dated 15 December 2021, a copy of which is available on the Company website at www.algwplc.com. The Board considers that these remain a current reflection of the risks and uncertainties facing the business for the remaining four months of the financial year.

 

Gobind Sahney

Director

29 September 2023

 

Alpha Growth plc

 

CONSOLIDATED Statement of comprehensive income

INTERIM period ENDED 30 june 2023

 

(Unaudited)

(Unaudited)

(Audited)

Six months

Six months

12 months

Ended

Ended

Ended

30.6.2023

30.6.2022

31.12.2022

Notes

 £

£

£

Continuing operations

 

Revenue from Owned Insurance Companies

2,222,909

1,463,768

3,424,875

Revenue from Contracts with Clients

275,801

169,677

346,787

 

Total revenue

 

2,498,710

1,633,445

3,771,662

Net movement on DAC/AVIF

(29,620)

33,447

(16,729)

Interest expense and investment costs

(4,673)

(7,189)

(27,838)

Bargain purchase

-

-

4,106,000

Expenses in managing owned insurance companies

(1,240,409)

(1,285,367)

(2,336,898)

Operating expenses

(1,547,596)

(828,971)

(2,403,021)

 

Profit/(loss) before taxation

 

(323,588)

(454,635)

3,093,176

Taxation

31,156

-

85,402

 

Profit/(loss) for the period

 

(292,432)

(454,635)

3,178,578

Other comprehensive income

 

Items that may be reclassified subsequently to profit or loss:

Exchange differences on foreign operations

(76,650)

-

192,270

 

Total comprehensive income

 

(369,082)

(454,635)

3,370,848

Attributable to:

Owners of the Company

(358,502)

(454,635)

3,178,359

Non-controlling Interests

(10,580)

-

192,489

(369,082)

(454,635)

3,370,848

Earnings / (loss) per share from continuing

 

operations attributable to the equity owners

 

Basic earnings / (loss) per share (pence)

3

(0.1p)

(0.1p)

0.7p

Fully diluted earnings / (loss) per share (pence)

3

(0.1p)

(0.1p)

0.4p

 

 

 

 

 

 

 

Alpha Growth plc

 

CONSOLIDATED Statement of Financial Position

AS AT 30 june 2023

 

(Unaudited)

(Unaudited)

(Audited)

As at

As at

As at

30.6.2023

30.6.2022

31.12.2022

Note

£

£

£

Assets

 

Intangible fixed asset

960,285

845,694

939,955

Right of use assets

173,096

258,574

183,672

Annuity contracts

7,091,321

-

7,063,374

Total assets in insurance business

435,310,844

214,843,900

454,303,995

Trade and other receivables

722,173

347,705

453,266

Cash and cash equivalents

113,281

44,479

218,530

Total assets

444,371,000

216,340,352

463,162,792

 

Equity and liabilities

 

Equity attributable to shareholders

 

Share capital

4

467,775

431,887

431,887

Share premium

4

6,248,962

5,388,152

5,388,152

Option reserve

669,948

480,674

815,474

Share based payment reserve

-

113,390

113,390

Foreign exchange reserve

124,857

201,473

182,748

Retained deficit

(787,166)

(3,902,468)

(505,314)

Total equity attributable to shareholders

6,724,376

2,713,108

6,426,337

Non-controlling interests

-

84,517

282,098

Total equity

6,724,376

2,797,625

6,708,435

Liabilities

 

Lease liabilities

 

202,513

271,239

238,483

Total liabilities in insurance business

429,900,054

213,091,992

447,956,125

Structured settlements

7,091,242

 

7,063,374

Trade and other payables

451,269

179,496

1,196,375

Income tax payable

1,546

-

-

Total liabilities

437,646,624

213,542,727

456,454,357

Total equity and liabilities

444,371,000

216,340,352

463,162,792

 

 

 

Company number: 09734404

Alpha Growth plc

 

CONSOLIDATED Statement of Changes in Equity

INTERIM period ENDED 30 june 2023

 

Share

 

Share

 

Option

 

Share-based

 

Foreign

 

Retained

 

Total

 

Non-

 

Total

 

Capital

 

 Premium

 

Reserve

 

Payment

 

Exchange

 

Deficit

 

Attributable to

 

Controlling

 

Reserve

 

Reserve

 

Shareholders

 

Interests

 

£

£

£

£

£

£

£

£

£

AS AT 31 DECEMBER 2021

431,887

 

5,404,313

 

480,674

 

113,390

 

-

 

(3,500,925)

 

2,929,339

 

89,609

 

3,018,948

 

Loss for the period

(449,543)

(449,543)

(5,092)

(454,635)

Foreign exchange gain on conversion of subsidiary

-

-

-

-

201,473

-

201,473

-

201,473

Total comprehensive income for the period

-

-

-

-

201,473

(449,543)

(248,070)

(5,092)

(253,162)

Share issue costs

-

(16,161)

-

-

-

-

(16,161)

-

(16,161)

AS AT 30 JUNE 2022

431,887

 

5,388,152

 

480,674

 

113,390

 

201,473

 

(3,950,468)

 

2,665,108

 

84,517

 

2,749,625

 

-

-

Profit for the period

-

-

-

-

-

3,445,154

3,445,154

188,059

3,633,213

Foreign exchange loss on conversion of subsidiary

-

-

-

-

(18,725)

-

(18,725)

9,522

(9,203)

Total comprehensive income for the period

-

-

-

-

(18,725)

3,445,154

3,426,429

197,581

3,624,010

Employee share options issued

-

-

334,800

-

-

-

334,800

-

334,800

AS AT 31 DECEMBER 2022

431,887

 

5,388,152

 

815,474

 

113,390

 

182,748

 

(505,314)

 

6,426,337

 

282,098

 

6,708,435

 

Loss for the period

-

-

-

-

-

(281,852)

(281,852)

(10,580)

(292,432)

Foreign exchange loss on conversion of subsidiary

-

-

-

-

(57,891)

-

(57,891)

(18,759)

(76,650)

Total comprehensive income for the period

-

-

-

-

(57,891)

(281,852)

(339,743)

(29,339)

(369,082)

Shares issued

35,888

860,810

-

-

-

-

896,698

-

896,698

Employee share options expired

-

-

(145,526)

-

-

-

(145,526)

-

(145,526)

Exercise of warrrants

-

-

-

(113,390)

-

-

(113,390)

-

(113,390)

Acquisition of non-controlling interests

-

-

-

-

-

-

-

(252,759)

(252,759)

AS AT 30 JUNE 2023

467,775

 

6,248,962

 

669,948

 

-

 

124,857

 

(787,166)

 

6,724,376

 

-

 

6,724,376

 

 

 

Alpha Growth plc

 

CONSOLIDATED Statement of Cash Flows

INTERIM PERIOD ENDED 30 june 2023

 

(Unaudited)

(Unaudited)

(Audited)

6 months

6 months

12 months

Ended

 Ended

Ended

30.6.2023

30.6.2022

31.12.2022

£

£

£

 

OPERATING ACTIVITIES

 

Loss for the period before interest and taxation

(318,915)

(447,446)

3,121,014

Adjusted for:

Services settled by way of payment in shares/options

(258,916)

-

334,800

Amortisation of intangible assets and right of use assets

39,150

22,670

116,699

Goodwill on the acquisition of non-controlling interests

(48,004)

-

-

Income tax paid

(2,208)

-

-

Operating cash outflows before movements in working capital:

(588,894)

(424,776)

3,572,513

(Increase)/decrease in trade and other receivables

(268,907)

(74,141)

(179,702)

Increase in non-tax net assets in insurance company

905,495

251,316

(4,460,717)

Increase/(decrease) in trade and other payables

(435,760)

117,777

726,657

 

Net cash used in operating activities

(388,066)

(129,824)

(341,249)

 

INVESTING ACTIVITIES

 

Acquisition of intangible asset

-

-

(113,387)

Acquisition of subsidiary (net of cash acquired)

-

-

193,493

Acquisition of non-controlling interest

(282,098)

-

-

 

Net cash inflow/(outflow) from investing activities

(282,098)

-

80,106

FINANCING ACTIVITIES

 

Repayment of leasing liabilities

(31,783)

2,130

(30,626)

Interest on leasing liabilities and loans

-

(7,189)

(19,063)

Loan finance

(300,000)

-

350,000

Net proceeds from issuance of shares net of issue costs

896,698

(16,161)

(16,161)

 

Net cash (outflow)/inflow from financing activities

564,915

(21,220)

284,150

Net (decrease)/increase in cash and cash equivalents

(105,249)

(151,044)

23,007

Cash and cash equivalents at beginning of period

218,530

195,523

195,523

 

Cash and cash equivalents at end of period

113,281

44,479

218,530

 

 

Alpha Growth plc

 

Notes to the Financial Statements

interim results to 30 june 2023

 

1. Organisation and Trading Activities

The company is incorporated and domiciled in England and Wales as a public limited company and operates from its registered office 35 Berkeley Square, Mayfair London, United Kingdom W1J 5BF

The principal activity of the Group is the provision of advice and consultancy services to institutional investors and existing and prospective holders of Senior Life Settlements through the management of its funds and the ownership of life insurance companies.

 

2. Summary of Significant Accounting Policies

The principal accounting policies adopted and applied in the preparation of these interim Group Financial statements are set out below.

These have been consistently applied to all the periods presented unless otherwise stated:

Basis of accounting

These interim financial statements of Alpha Growth plc (the "Group") have been prepared in accordance with UK adopted international accounting standards ("UK-adopted IAS") applied in accordance with the provisions of the Companies Act 2006.

The interim financial statements have been prepared under the historical cost convention on the basis of the accounting policies as set out in the Group's audited annual financial statements and are presented in GBP £ the presentational and functional currency of the Group. The Group has applied IAS 34 in the preparation of these interim financial statements.

This announcement was approved and authorised by the Board of directors on 28 September 2023. Copies of this interim report will be made available on the Company's website at www.algwplc.com.

These condensed interim financial statements for the six months ended 30 June 2023 are unaudited and do not constitute fully prepared statutory accounts. The comparative figures for the 12 month period ended 31 December 2022 are extracted from the 2022 audited financial statements. The independent auditor's report on the 2022 financial statements was not qualified.

Going concern

Any consideration of the foreseeable future involves making a judgement, at a particular point in time, about future events which are inherently uncertain.

The Directors have a reasonable expectation that the Group has sufficient cash and liquid reserves in order to meet any future obligations and thus to continue operating for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the Financial Statements.

 

3. EARNINGS per Share

The basic earnings per share is based on the loss for the period divided by the weighted average number of shares in issue during the year. The weighted average number of ordinary shares for the Company the period ended 30 June 2023 assumes that all shares have been included in the computation based on the weighted average number of days since issue. Since the Group has made a loss in the current and each of the prior periods, the warrants in issue are not dilutive. 

30.6.2023

30.6.2022

31.12.2022

£

£

£

Profit/(loss) for the period from continuing operations:

(292,432)

(454,635)

3,178,578

Weighted average number of ordinary shares in issue for basic earnings

447,084,823

431,887,388

431,887,388

Fully diluted average number of shares in issue

447,084,823

431,887,388

777,100,388

Basic earnings / (loss) per share

(0.1p)

(0.1p)

0.7p

Fully diluted earnings / (loss) per share

(0.1p)

(0.1p)

0.4p

 

4. Share capital AND SHARE PREMIUM

Ordinary shares of £0.001 each

 Share capital

Share premium

 

Number

£

£

 

At 1 January 2022

431,887,388

431,887

5,404,313

 

Costs related to listing of shares issued 15 March 2021

-

-

(16,161)

At 31 December 2022

431,887,388

431,887

5,388,152

 

Warrant exercise

18,750,000

18,750

469,640

Share issue

17,137,680

17,138

421,780

Costs of issue

-

-

(30,610)

At 30 June 2023

467,775,068

467,775

6,248,962

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR NKFBDNBKBACB
Date   Source Headline
22nd Dec 20239:00 amRNSExpiration of Warrants
13th Dec 20237:00 amRNSAlpha International Life Receives KBRA Rating
14th Nov 20233:36 pmRNSJason Sutherland Receives Industry Recognition
9th Oct 20234:00 pmRNSHolding(s) in Company
9th Oct 20232:43 pmRNSHolding(s) in Company
29th Sep 202311:00 amRNSHalf-year Report
14th Aug 20236:29 pmRNSHolding(s) in Company
19th Jun 20237:00 amRNSResult of AGM
6th Jun 20237:00 amRNSNotice of AGM
15th May 20237:00 amRNSAcquisition of Minority Holding and Share Issuance
3rd May 20237:00 amRNSHolding(s) in Company
2nd May 20237:00 amRNS2022 Annual Report & Financial Statements
15th Mar 20237:00 amRNSWarrant Exercise and Total Voting Rights
6th Mar 20237:00 amRNS2022 Annual Recap and Fund Results
8th Feb 20234:40 pmRNSSecond Price Monitoring Extn
8th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20231:10 pmRNSHolding(s) in Company
20th Jan 20232:05 pmRNSSecond Price Monitoring Extn
20th Jan 20232:00 pmRNSPrice Monitoring Extension
20th Jan 202311:05 amRNSSecond Price Monitoring Extn
20th Jan 202311:00 amRNSPrice Monitoring Extension
12th Dec 20227:00 amRNSFurther Regarding Havelet Acquisition
6th Dec 20227:00 amRNSCompletion of Share Purchase Acquisition
17th Nov 20227:00 amRNSFinancial Services Company Acquistion
27th Oct 20227:00 amRNSChange of Adviser
26th Oct 20224:41 pmRNSSecond Price Monitoring Extn
26th Oct 20224:36 pmRNSPrice Monitoring Extension
3rd Oct 20224:40 pmRNSSecond Price Monitoring Extn
3rd Oct 20224:35 pmRNSPrice Monitoring Extension
3rd Oct 20222:06 pmRNSSecond Price Monitoring Extn
3rd Oct 20222:00 pmRNSPrice Monitoring Extension
3rd Oct 202211:06 amRNSSecond Price Monitoring Extn
3rd Oct 202211:01 amRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSHalf-year Report
28th Sep 20227:00 amRNSAppointment as Investment Manager/Insurance Update
12th Sep 20222:06 pmRNSSecond Price Monitoring Extn
12th Sep 20222:00 pmRNSPrice Monitoring Extension
9th Sep 20222:06 pmRNSSecond Price Monitoring Extn
9th Sep 20222:00 pmRNSPrice Monitoring Extension
8th Sep 20227:00 amRNSDirector and Personnel Announcement
3rd Aug 20227:00 amRNSHolding(s) in Company
26th Jul 20224:40 pmRNSSecond Price Monitoring Extn
26th Jul 20224:35 pmRNSPrice Monitoring Extension
20th Jun 20224:03 pmRNSResults of the Annual General Meeting
31st May 20227:00 amRNSRelease of 2021 Annual Report
27th Apr 20227:00 amRNSShareholder Information Update
24th Mar 20224:41 pmRNSSecond Price Monitoring Extn
24th Mar 20224:36 pmRNSPrice Monitoring Extension
24th Mar 20222:05 pmRNSSecond Price Monitoring Extn
24th Mar 20222:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.